For Moderna, COVID vaccines were a ‘proof of concept’ — now comes the big test

Following Moderna’s COVID-19 vaccine success, therapeutics head Dr. Kyle Holen discusses scaling mRNA development to bring candidates to the finish line in oncology and more.